Cargando…

Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients

BACKGROUND: A substantial proportion of critically ill COVID-19 patients develop thromboembolic complications, but it is unclear whether higher doses of thromboprophylaxis are associated with lower mortality rates. The purpose of the study was to evaluate the association between initial dosing strat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jonmarker, Sandra, Hollenberg, Jacob, Dahlberg, Martin, Stackelberg, Otto, Litorell, Jacob, Everhov, Åsa H., Järnbert-Pettersson, Hans, Söderberg, Mårten, Grip, Jonathan, Schandl, Anna, Günther, Mattias, Cronhjort, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680989/ https://www.ncbi.nlm.nih.gov/pubmed/33225952 http://dx.doi.org/10.1186/s13054-020-03375-7

Ejemplares similares

A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-19
por: Jonmarker, Sandra, et al.
Publicado: (2023)

Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial
por: Jonmarker, Sandra, et al.
Publicado: (2023)

Adequate thromboprophylaxis in critically ill patients
por: Levi, Marcel
Publicado: (2010)

Renal function and thromboprophylaxis in critically ill patients
por: Scholey, Gareth M, et al.
Publicado: (2010)

Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients
por: Piagnerelli, Michaël, et al.
Publicado: (2020)

Fluid accumulation and major adverse kidney events in sepsis: a multicenter observational study
por: Mele, Alessandro, et al.
Publicado: (2022)

Heparin thromboprophylaxis in critically ill patients: Is it really changing outcome?
por: Gurjar, Mohan
Publicado: (2014)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Intensified thromboprophylaxis in COVID-19 critically ill patients: Is it enough?
por: de Montmollin, Etienne, et al.
Publicado: (2021)

Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
por: Bachler, Mirjam, et al.
Publicado: (2022)

Thromboprophylaxis in critical care
por: Helms, Julie, et al.
Publicado: (2022)

Cognitive Behavioral Therapy and Acceptance and Commitment Therapy (CBT-ACT) vs. Standard Care After Critical Illness Due to COVID-19: Protocol for a Pilot Randomized Controlled Trial
por: Håkansson, Anders, et al.
Publicado: (2022)

Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
por: Lauzier, François, et al.
Publicado: (2014)

Long‐term consequences in critically ill COVID‐19 patients: A prospective cohort study
por: Schandl, Anna, et al.
Publicado: (2021)

COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
por: Ferrandis, Raquel, et al.
Publicado: (2020)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

What Do We Know about Thromboprophylaxis and Its Monitoring in Critically Ill Patients?
por: Cauchie, Philippe, et al.
Publicado: (2021)

Out of hospital cardiac arrest outside home in Sweden, change in characteristics, outcome and availability for public access defibrillation
por: Ringh, Mattias, et al.
Publicado: (2009)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Risk factors for and prediction of mortality in critically ill medical–surgical patients receiving heparin thromboprophylaxis
por: Li, Guowei, et al.
Publicado: (2016)

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials
por: Park, Jonghanne, et al.
Publicado: (2016)

Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection
por: Fattorutto, Maurizio, et al.
Publicado: (2021)

Retained sex toys: an increasing and possibly preventable medical condition
por: Dahlberg, Martin, et al.
Publicado: (2018)

Prone positioning in mechanically ventilated patients with severe acute respiratory distress syndrome and coronavirus disease 2019
por: Gleissman, Helena, et al.
Publicado: (2020)

New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
por: MacDougall, Kira, et al.
Publicado: (2020)

A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
por: Robinson, Sian, et al.
Publicado: (2013)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

High level of venous thromboembolism in critically ill trauma patients despite early and well-driven thromboprophylaxis protocol
por: Hamada, S. R., et al.
Publicado: (2017)

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data
por: Alrashed, Ahmed, et al.
Publicado: (2022)

Effectiveness of thromboprophylaxis with low molecular weight heparin in critically ill patients with COVID-19. An observational prospective, multicenter study
por: Ferrandis, R., et al.
Publicado: (2023)

Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach
por: Sahle, Berhe W., et al.
Publicado: (2023)

Developing a screening instrument for predicting psychological morbidity after critical illness
por: Schandl, A, et al.
Publicado: (2013)

Developing an early screening instrument for predicting psychological morbidity after critical illness
por: Schandl, Anna, et al.
Publicado: (2013)

Bench-to-bedside review: Nitric oxide in critical illness – update 2008
por: Hollenberg, Steven M, et al.
Publicado: (2009)

The role of ventilatory support for long‐term outcomes after critical infection with COVID‐19: A prospective cohort study
por: Hanna, Gabriel, et al.
Publicado: (2021)

Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors
por: Cook, Deborah, et al.
Publicado: (2008)

Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
por: Pai, Menaka, et al.
Publicado: (2018)

Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis
por: Zhang, Cong, et al.
Publicado: (2020)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Hafiz, Awatif, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6pi262e84f950gc072leuvjon7